On Thursday shares of Micron Technology, Inc. (NASDAQ:MU) closed at $29.51. Company’s sales growth for last 5 years was 27.80% and EPS growth for next 5 years is recorded as 15.00%. Argus upgraded shares of Micron Technology, Inc. (NASDAQ:MU) to a buy rating in a research note released on Monday morning. They currently have $41.00 target price on the stock.
Merck & Co. Inc. (NYSE:MRK) in last trading activity moved down -0.31% to close at $57.51. Company weekly performance is -0.57% while its quarterly performance stands at -7.37%. Merck & Co. Inc. (NYSE:MRK) is -8.87% away from its 52 week high. On 20 April, Merck & Co. Inc. (NYSE:MRK) has announced that it has submitted an application to the U.S. Food and Drug and Administration (FDA) seeking approval for its cancer drug Keytrada that is designed to treat patients with non-small cell lung cancer (NSCLC) after a study comparing the drug against rival cancer treatments by Bristol-Myers Squibb Co. was published
On last trading day Bio-Rad Laboratories, Inc. (NYSE:BIO) moved up 0.56% to close at $137.40. Its volatility for the week is 1.17% while volatility for the month is 1.13%. BIO’s sales growth for past 5 years was 4.00% and its EPS growth for past 5 years was -10.10%. Bio-Rad Laboratories, Inc. (NYSE:BIO) monthly performance is 1.65%. On 20 April, Bio-Rad Laboratories, Inc. (NYSE:BIO) announced that Bio-Rad is extending its agreement with Beckman Coulter and has named the company exclusive global distributor of Bio-Rad’s Access HIV combo assay and the Access hepatitis C virus (HCV) assay in select geographies. (The products are not available in the U.S. or Vietnam).
MasTec, Inc. (NYSE:MTZ) has 4.20% insider ownership while its institutional ownership stands at 81.30%. In last trading activity company’s stock closed at $17.75. On 13 April, MasTec, Inc. (NYSE:MTZ) reported it has successfully completed its previously announced consent solicitation, seeking extension of reporting requirements under the indenture governing its $400 million Senior Notes due March 15, 2023 (the “Notes”).
Alcatel Lucent SA (ADR) (NYSE:ALU) in last trading activity moved down -2.18% to close at $4.03. Company weekly performance is 1.77% while its quarterly performance stands at 16.81%. Alcatel Lucent SA (ADR) (NYSE:ALU) is -18.75% away from its 52 week high. On 15 April, Alcatel Lucent SA (ADR) (NYSE:ALU) said that, Nokia Oyj agreed to buy Alcatel-Lucent SA in an all-stock deal valued at 15.6 billion euros ($16.6 billion) to create the world’s largest supplier of equipment that powers mobile-phone networks.